Results 101 to 110 of about 4,431,933 (293)

Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades [PDF]

, 2019
Background: The importance of primary biliary cholangitis as an indication for liver transplantation has probably been influenced by the introduction of therapies, and changes in selection criteria and disease epidemiology.
Harms, Maren, Klempnauer, J.L., Hansen, B.E. (Bettina), Pratschke, J. (Johann), van Buuren, Henk, Pinzani, M., Darius Mirza, Pratschke, J, Bennet, W., Stephen J. Wigmore, Wigmore, SJ, Herold J. Metselaar, Metselaar, H.J. (Herold), Helena Isoniemi, Metselaar, Herold, Hidalgo, E., Janssen, Kiki, Pinzani, M, Vincent Karam, Hansen, Bettina, Jurgen L. Klempnauer, Mirza, D., Duvoux, C, van Buuren, H.R., Rene Adam, Henk R. van Buuren, Duvoux, C., Bennet, W, Watson, C. (Craig), Christophe Duvoux, Watson, C, Karam, V, Klempnauer, JL, Krzysztof Zieniewicz, Mirza, D, Adam, R. (René), Isoniemi, H, Ernest Hidalgo, William Bennet, Hidalgo, E, Harms, M.H., Zieniewicz, K., Massimo Pinzani, Johann Pratschke, Zieniewicz, K, Isoniemi, H. (Helena), Adam, R, Wigmore, S.J., Christopher Watson, Quisette P. Janssen, Karam, V. (Vincent), Bettina E. Hansen, Janssen, Q.P., Maren H. Harms   +53 more
core   +4 more sources

Clinical Evaluation of the Effectiveness of Digital Peroral Cholangioscopy‐Guided Lithotripsy for Difficult Bile Duct Stones

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background and Aims Peroral cholangioscopy‐guided lithotripsy (POCS‐L) has emerged as a treatment option for difficult bile duct stones (DBDSs), but detailed evidence remains limited. This study evaluated its effectiveness, safety, and risk factors for adverse events (AEs).
Hirohito Minami, Shuntaro Mukai, Takayoshi Tsuchiya, Reina Tanaka, Ryosuke Tonozuka, Kazumasa Nagai, Hiroyuki Kojima, Noriyuki Hirakawa, Kyoko Asano, Takao Itoi   +9 more
wiley   +1 more source

Comparison of clinical characteristics (demographics and liver biochemistry) in patients with primary biliary Cholangitis-Autoimmune hepatitis overlap syndrome and primary biliary cholangitis alone.

, 2018
Comparison of clinical characteristics (demographics and liver biochemistry) in patients with primary biliary Cholangitis-Autoimmune hepatitis overlap syndrome and primary biliary cholangitis alone.
Natalia Baeza (4976468), Andrew L. Mason (403408), Gary L. Norman (361506), Henry H. Nguyen (2318311), Stefan J. Urbanski (4976465), Marvin J. Fritzler (239571), Abdel Aziz Shaheen (4976474), Ellina Lytvyak (4976471), Mark G. Swain (587680)   +8 more
core   +1 more source

Characteristics of ascitic fluid and diagnosis of bacterial peritonitis in malignant ascites: An observational study

Journal of Hospital Medicine, EarlyView.
Abstract Background Bacterial peritonitis in patients with malignant ascites (BP‐MA) is an understudied, high‐mortality condition. While ascitic polymorphonuclear (PMN) cell count ≥ 250 cells/mm3 defines the diagnosis of spontaneous bacterial peritonitis (SBP) in patients with cirrhosis, an ascitic fluid parameter for the diagnosis of BP‐MA has not ...
Mark M. Kelly, Nicole Johnston, Joanne Kuznicki, Stacy A. Johnson, Hannah Imlay   +4 more
wiley   +1 more source

Primary biliary cholangitis: symptoms, diagnosis and treatment

, 2019
Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is a chronic but progressive disease that, over many years, causes damage to bile ducts, leading to cholestasis and, in some patients, cirrhosis.
Mortimore, Gerri
core  

Comparisons of frequencies of autoantibodies in patients with primary biliary cholangitis autoimmune hepatitis overlap syndrome (PBC-AIH OS) and patients with Primary Biliary Cholangitis (PBC) alone.

, 2018
Comparisons of frequencies of autoantibodies in patients with primary biliary cholangitis autoimmune hepatitis overlap syndrome (PBC-AIH OS) and patients with Primary Biliary Cholangitis (PBC) alone.
Natalia Baeza (4976468), Andrew L. Mason (403408), Gary L. Norman (361506), Henry H. Nguyen (2318311), Stefan J. Urbanski (4976465), Marvin J. Fritzler (239571), Abdel Aziz Shaheen (4976474), Ellina Lytvyak (4976471), Mark G. Swain (587680)   +8 more
core   +1 more source

Impact of cystic fibrosis transmembrane conductance regulator modulator therapies on liver stiffness and liver enzymes: An observational perspective single‐center cohort study

JPGN Reports, EarlyView.
Abstract Objectives The efficacy of cystic fibrosis transmembrane conductance regulator (CFTR)‐modulator therapies in preventing or ameliorating cystic fibrosis liver disease (CFLD) by correcting CFTR in cholangiocytes is not well‐documented. This study aimed to assess liver function during CFTR‐modulators.
Laura Giugliano, Elisabetta Augustoni, Antonio Pizzol, Anna Opramolla, Cristina Chiadò, Anna Zagaria, Irene Esposito, Giulia Roberto, Alice Ponte, Andrea Evangelista, Paola Quarello, Michele Pinon, Pier Luigi Calvo   +12 more
wiley   +1 more source

Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis

Future Science OA, 2020
Aim: To assess the ability of signature metabolites alone, or in combination with the model for end-stage liver disease-Na (MELD-Na) score to predict mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing ...
Ayse L Mindikoglu, Cristian Coarfa, Antone R Opekun, Vijay H Shah, Juan P Arab, Konstantinos N Lazaridis, Nagireddy Putluri, Chandrashekar R Ambati, Matthew J Robertson, Sridevi Devaraj, Prasun K Jalal, Abbas Rana, John A Goss, Thomas C Dowling, Matthew R Weir, Stephen L Seliger, Jean-Pierre Raufman, David W Bernard, John M Vierling   +18 more
doaj   +1 more source

Effects of post‐hepatic portoenterostomy adjuvant therapy on liver transplantation in children with biliary atresia: A systematic review

JPGN Reports, EarlyView.
Abstract Objectives Biliary atresia (BA) is a cholangiopathy characterized by obstruction of the intrahepatic and extrahepatic bile ducts. Hepatic portoenterostomy (HPE) is the primary palliative treatment and there is still an urgent need to improve post‐HPE management.
Bianca Ferraz de Almeida Silva, Alice Palmeira Nascimento Cerqueira, Breno Oliveira Marques, Gabriela Garcia de Carvalho Laguna, Gabrielle dos Santos Aguiar, Luana Leal Gonzaga, Raquel Teles de Lacerda, Natalia Oliveira e Silva   +7 more
wiley   +1 more source

Cellular Interactions and Crosstalk Facilitating Biliary Fibrosis in CholestasisSummary

Cellular and Molecular Gastroenterology and Hepatology
Biliary fibrosis is seen in cholangiopathies, including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). In PBC and PSC, biliary fibrosis is associated with worse outcomes and histologic scores.
Ludovica Ceci, Eugenio Gaudio, Lindsey Kennedy   +2 more
doaj   +1 more source